# Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-sglt2-inhibitors-on-type-2-diabetes-mellitus-with-non-alcoholic-fatty/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qiong Wei,Xinyue Xu,Li Guo,Jia Li,Ling Li |
| Citations | 105 |
| DOI | 10.3389/fendo.2021.635556 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fendo.2021.635556/pdf |
| OpenAlex ID | https://openalex.org/W3175909657 |
| PMID | 34220701 |
| Type | review |
| Year | 2021 |

## Paper authors

- [Xinyue Xu](https://scholariq.org/researchers/xinyue-xu/)

## Paper journal

- [Frontiers in Endocrinology](https://scholariq.org/journals/frontiers-in-endocrinology/)

## Paper primary topic

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Paper topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.